(NASDAQ: GOVX) Geovax Labs's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.59%.
Geovax Labs's earnings in 2025 is -$24,992,296.On average, 3 Wall Street analysts forecast GOVX's earnings for 2025 to be -$29,432,418, with the lowest GOVX earnings forecast at -$33,076,352, and the highest GOVX earnings forecast at -$26,295,008. On average, 1 Wall Street analyst forecast GOVX's earnings for 2026 to be -$26,433,403, with the lowest GOVX earnings forecast at -$26,433,403, and the highest GOVX earnings forecast at -$26,433,403.
In 2027, GOVX is forecast to generate -$1,107,158 in earnings, with the lowest earnings forecast at -$1,107,158 and the highest earnings forecast at -$1,107,158.